Drug Trial Radar · NCT00408174
Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Planned (sponsor's estimate)
Start
May 2006
Primary completion
Jul 2007
Study completion Nov 2007
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 6, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice daily in achieving clinical improvement in subjects with mildly to moderately active ulcerative colitis after 6 weeks of therapy.
Conditions
- Inflammatory Bowel Disease
- Ulcerative Colitis
Interventions
Balsalazide disodiumDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary efficacy endpoint is the proportion of subjects that achieve clinical improvement and improvement in the rectal bleeding subscale of the MMDAI at the end of six weeks of therapy.
Locations
88 sites in 1 country. Site status is shown where the registry gives one.
Premiere Pharmaceutical Research
Tempe, Arizona
Arizona Clinical Research Center
Tucson, Arizona
Medical Services of Northwest Arkansas
Fayetteville, Arkansas
Gastroenterology Associates
Little Rock, Arkansas
AGMG Clinical Research Institute
Anaheim, California
West Gastroenterology Medical Group
Los Angeles, California
Sharp Rees-Stealy Medical Group
San Diego, California
Rocky Mountain Gastroenterology
Lakewood, Colorado
Arapahoe Gastroenterology, PC
Littleton, Colorado
South Denver Gastroenterology
Lone Tree, Colorado
Phoenix Internal Medical Associates
Waterbury, Connecticut
Clinical Trials Management of Bocal Raton
Boca Raton, Florida
Research Consultants Group
Hialeah, Florida
Horizon Institute for Clinical Researcg
Hollywood, Florida
Mark Lamet, M.D.
Hollywood, Florida
Borland-Grover Clinic
Jacksonville, Florida
A+ Research
Miami, Florida
West Wind'r Research & Development
Tampa, Florida
Shafran Gastroenterology Center
Winter Park, Florida
Florida Medical Clinic
Zephyrhills, Florida
The Atlanta Center for Gastroenterology
Atlanta, Georgia
Atlanta Gastroenterology Associates
Atlanta, Georgia
Atlanta Academic Research
Decatur, Georgia
Gastroenterology Associates of Central Georgia
Macon, Georgia
Digestive Research Associates
Newnan, Georgia
University of Illinois at Chicago
Chicago, Illinois
Carle Clinic Association
Urbana, Illinois
Community Clinical Research Center
Anderson, Indiana
Iowa Digestive Disease Center
Clive, Iowa
University of Kentucky Medical Center
Lexington, Kentucky
Clinical Trials Management
Metairie, Louisiana
Digestive Disorders Association
Annapolis, Maryland
Maryland Clinical Trials
Annapolis, Maryland
Alan Rosen, M.D.
Baltimore, Maryland
Digestive Disease Associates
Baltimore, Maryland
Chevy Chase Clinical Research
Chevy Chase, Maryland
The Center for Clinical Research
Hagerstown, Maryland
Charm City Research
Lutherville, Maryland
Coastal Research Associates
Braintree, Massachusetts
Gastroenterology Associates of Western Michigan
Grand Rapids, Michigan
Showing 40 of 88 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.